Leech-Assisted Flap Salvage — Systematic Review of 277 Cases
Evidence base for the FDA-cleared microsurgical indication
Why this matters for hirudotherapy
FDA-Cleared Indication
FDA-cleared indication. Medicinal leeches are FDA 510(k)-cleared for relief of venous congestion following reconstructive surgery.
Scope and methodology
Whitaker et al. conducted the most comprehensive systematic review of leech-assisted tissue salvage to date, analyzing 277 reported cases across 67 publications spanning 1966–2009. The review covered free flap reconstructions, pedicled flaps, replantations, and composite tissue transfers where leeches were used to manage venous congestion — the FDA-cleared indication.[R1]
Key findings
60–83%
Overall flap salvage rate
88.3%
Salvage without infection
37.4%
Salvage with Aeromonas
The infection paradox
The review’s most significant finding was the dramatic impact of Aeromonas infection on outcomes. Medicinal leeches carry Aeromonas species as obligate gut symbionts — bacteria essential for the leech’s digestion of blood meals. This creates an inherent infection risk during any leech application.
When Aeromonas infection occurred, the flap salvage rate dropped catastrophically — from 88.3% to just 37.4%. This 50-percentage-point reduction established infection prophylaxis as the single most important modifiable factor in leech-assisted flap salvage outcomes.[R1]
Mechanisms of salvage
The review identified three overlapping mechanisms by which leeches relieve venous congestion:
1. Active extraction
Each leech ingests 5–15 mL of blood during feeding, providing immediate mechanical decompression of the congested tissue.
2. Passive oozing
The anticoagulant-rich bite wound continues to ooze for 4–48 hours post-detachment, removing an additional 50–150 mL per bite site — the primary therapeutic mechanism.
3. Vasodilation
Salivary compounds promote local vasodilation and microcirculatory improvement, enhancing tissue perfusion beyond the immediate bite area.
Clinical implications
The review established several evidence-based recommendations that have shaped modern clinical practice:
| Factor | Evidence | Recommendation |
|---|---|---|
| Antibiotic prophylaxis | 88.3% vs 37.4% with/without infection | Mandatory fluoroquinolone prophylaxis |
| Timing | Earlier intervention = better outcomes | Initiate within 24 hours of congestion |
| Monitoring | Blood loss requires tracking | Serial Hgb monitoring; transfusion threshold |
Timing as prognostic factor
A subsequent systematic review by Herlin et al. (2017) extended the Whitaker analysis and identified timing as the dominant prognostic variable: flap salvage was 83.7% when leeches were applied within 24 hours of congestion onset, but dropped to just 38.6% beyond 24 hours — a 45-percentage-point decline. This finding underscores the urgency of early recognition and intervention for venous congestion.
Infection risk is manageable
References
- [R1]
By What Mechanism Do Leeches Help to Salvage Ischaemic Tissues After Reconstructive Surgery? A Systematic Review
Primary source. Largest systematic review of leech-assisted flap salvage.
- [R2]
Leech Therapy in Flap Salvage: Systematic Review and Practical Recommendations
Journal of Plastic, Reconstructive & Aesthetic Surgery(2017)https://doi.org/10.1016/j.bjps.2016.09.009Herlin et al. follow-up review establishing timing as dominant prognostic variable.
- [R3]
Medicinal Leech Use in Microsurgery: A Practical Review
Nguyen et al. reviewing institutional protocols and prophylaxis strategies.
Related Resources
Added to ASH library: February 27, 2026 | Site last updated: March 14, 2026